By Carolyn Y. Johnson
In a subterranean ballroom Wednesday morning, a panel representing three corners of the health care system took on one of the most perplexing questions about drug prices: Why does the U.S. pay so much more for brand name drugs than other wealthy nations?
The U.S. drug price premium has been shown again and again. It depends on the drug and the country, but a Reuters analysis found that the U.S. pays as much as seven times more than the United Kingdom for some top-selling drugs.
Continue reading...
No comments:
Post a Comment